前扣带皮层脑深部电刺激治疗神经病理性疼痛的长期结果
24例药物难治性神经病理性疼痛患者接受双侧前扣带皮层脑深部电刺激,术后6个月NRS评分从8.0降至4.27(P=0.004),MPQ和EQ-5D显著改善;部分患者疗效持续至42个月。随访结果证实该疗法可减轻疼痛并改善生活质量。
要点
- 双侧前扣带皮层脑深部电刺激术后6个月NRS评分从8.0降至4.27(P=0.004)。
- 术后6个月MPQ平均改善36%(P=0.021),EQ-5D平均降低21%(P=0.036)。
- 部分患者疗效持续至42个月,NRS评分低至3。
核心结论
- 随访结果证实前扣带皮层脑深部电刺激可减轻药物难治性慢性神经病理性疼痛,并改善许多患者的生活质量。
研究设计与样本
- 24例神经病理性疼痛患者(19例男性;平均年龄49.1岁)接受双侧前扣带皮层脑深部电刺激。
- 采用NRS、SF-36、MPQ和EQ-5D问卷在术前和术后收集患者报告结局指标。
主要发现
- 22例患者在试验周后完全内化,其中12例平均随访38.9个月。
- 术后6个月平均NRS评分从8.0降至4.27(P=0.004)。
- MPQ显著改善(平均-36%;P=0.021),EQ-5D评分显著降低(平均-21%;P=0.036)。
- SF-36躯体功能域显著改善(平均+54.2%;P=0.01)。
- 在这些患者中,83%在6个月时NRS评分改善60%(P<0.001),MPQ降低47%(P<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep brain stimulation (DBS) of the anterior cingulate cortex (ACC) is a recent technique that has shown some promising short-term results in patients with chronic refractory neuropathic pain. Three years after the first case series, we assessed its efficacy on a larger cohort, with longer follow-up. METHODS: Twenty-four patients (19 males; average age, 49.1 years) with neuropathic pain underwent bilateral ACC DBS. Patient-reported outcome measures were collected before and after surgery, using the Numerical Rating Scale (NRS), Short-Form 36 quality of life (SF-36), McGill Pain Questionnaire (MPQ), and EuroQol 5-domain quality of life (EQ-5D) questionnaire. RESULTS: Twenty-two patients after a trial week were fully internalized and 12 had a mean follow-up of 38.9 months. Six months after surgery the mean NRS score decreased from 8.0 to 4.27 (P = 0.004). There was a significant improvement in the MPQ (mean, -36%; P = 0.021) and EQ-5D score significantly decreased (mean, -21%; P = 0.036). The physical functioning domain of SF-36 was significantly improved (mean, +54.2%; P = 0.01). Furthermore, in 83% of these patients, at 6 months, NRS score was improved by 60% (P < 0.001) and MPQ decreased by 47% (P < 0.01). After 1 year, NRS score decreased by 43% (P < 0.01), EQ-5D was significantly reduced (mean, -30.8; P = 0.05) and significant improvements were also observed for different domains of the SF-36. At longer follow-ups, efficacy was sustained up to 42 months in some patients, with an NRS score as low as 3. CONCLUSIONS: Follow-up results confirm that ACC DBS alleviates chronic neuropathic pain refractory to pharmacotherapy and improves quality of life in many patients.
引用
- Boccard SGJ, Prangnell SJ, Pycroft L, et al. Long-Term Results of Deep Brain Stimulation of the Anterior Cingulate Cortex for Neuropathic Pain. World Neurosurg. 2017. PMID: 28710048. doi:10.1016/j.wneu.2017.06.173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。